Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.

Source:http://linkedlifedata.com/resource/pubmed/id/17199867

Download in:

View as

General Info

PMID
17199867